메뉴 건너뛰기




Volumn 6, Issue , 2016, Pages

Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle

(23)  Dye, John M a   Wu, Hua b   Hooper, Jay W a   Khurana, Surender c   Kuehne, Ana I a   Coyle, Elizabeth M c   Ortiz, Ramon A a   Fuentes, Sandra c   Herbert, Andrew S a   Golding, Hana c   Bakken, Russell A a   Brannan, Jennifer M a   Kwilas, Steve A a   Sullivan, Eddie J b   Luke, Thomas C d   Smith, Gale e   Glenn, Gregory e   Li, Wenfang f   Ye, Ling f   Yang, Chinglai f   more..


Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

EID: 84964658344     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24897     Document Type: Article
Times cited : (33)

References (32)
  • 3
    • 0032907635 scopus 로고    scopus 로고
    • Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virusinfected patients
    • Baize, S. et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virusinfected patients. Nature Medicine 5, 423-426 (1999).
    • (1999) Nature Medicine , vol.5 , pp. 423-426
    • Baize, S.1
  • 4
    • 0034709761 scopus 로고    scopus 로고
    • Human asymptomatic Ebola infection and strong inflammatory response
    • Leroy, E. M. et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355, 2210-2215 (2000).
    • (2000) Lancet , vol.355 , pp. 2210-2215
    • Leroy, E.M.1
  • 6
    • 0036100307 scopus 로고    scopus 로고
    • Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody
    • Parren, P. W. et al. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Viro l76(12), 6408-12 (2002).
    • (2002) J Viro , vol.176 , Issue.12 , pp. 6408-6412
    • Parren, P.W.1
  • 7
    • 33846490649 scopus 로고    scopus 로고
    • Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
    • Oswald, W. B. et al. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLos Pathog 3(1), p. e9 (2007).
    • (2007) PLos Pathog , vol.3 , Issue.1 , pp. e9
    • Oswald, W.B.1
  • 8
    • 84859462127 scopus 로고    scopus 로고
    • Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
    • Dye, J. M. et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci USA 109(13), p. 5034-9 (2012).
    • (2012) Proc Natl Acad Sci USA , vol.109 , Issue.13 , pp. 5034-5039
    • Dye, J.M.1
  • 9
    • 84907263545 scopus 로고    scopus 로고
    • Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
    • Qiu, X. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47-53 (2014).
    • (2014) Nature , vol.514 , pp. 47-53
    • Qiu, X.1
  • 10
    • 84912116176 scopus 로고    scopus 로고
    • Fighting Ebola with ZMapp: Spotlight on plant-made antibody
    • Zhang, Y., Li, D., Jin, X. & Huang, Z. Fighting Ebola with ZMapp: spotlight on plant-made antibody. Science China Life sciences 57, 987-988 (2014).
    • (2014) Science China Life Sciences , vol.57 , pp. 987-988
    • Zhang, Y.1    Li, D.2    Jin, X.3    Huang, Z.4
  • 11
    • 84862525229 scopus 로고    scopus 로고
    • Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies
    • 138ra181
    • Qiu, X. et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 4, 138ra181, doi: 10.1126/scitranslmed.3003876 (2012).
    • (2012) Sci Transl Med , vol.4
    • Qiu, X.1
  • 12
    • 84912064043 scopus 로고    scopus 로고
    • US signs contract with ZMapp maker to accelerate development of the Ebola drug
    • McCarthy, M. US signs contract with ZMapp maker to accelerate development of the Ebola drug. BMJ 349, doi: 10.1136/bmj.g5488. (2014).
    • (2014) BMJ , vol.349
    • McCarthy, M.1
  • 13
    • 0033062193 scopus 로고    scopus 로고
    • Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee
    • Mupapa, K. et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 179 Suppl 1, S18-23 (1999).
    • (1999) J Infect Dis , vol.179 , pp. S18-S23
    • Mupapa, K.1
  • 14
    • 0033035994 scopus 로고    scopus 로고
    • Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: Determinants of survival
    • Sadek, R. F., Khan, A. S., Stevens, G., Peters, C. J. & Ksiazek, T. G. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis 179 Suppl 1, S24-27 (1999).
    • (1999) J Infect Dis , vol.179 , pp. S24-S27
    • Sadek, R.F.1    Khan, A.S.2    Stevens, G.3    Peters, C.J.4    Ksiazek, T.G.5
  • 15
    • 77950219752 scopus 로고    scopus 로고
    • Hark back: Passive immunotherapy for influenza and other serious infections
    • Luke, T. C. et al. Hark back: passive immunotherapy for influenza and other serious infections. Crit Care Med 38 (4 Suppl), e66-73, doi: 10.1097/CCM.0b013e3181d44c1e (2010).
    • (2010) Crit Care Med , vol.38 , Issue.4 , pp. e66-e73
    • Luke, T.C.1
  • 16
    • 0034821759 scopus 로고    scopus 로고
    • Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases
    • Hemming, V. G. Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases. Clin Diagn Lab Immunol 8, 859-863 (2001).
    • (2001) Clin Diagn Lab Immunol , vol.8 , pp. 859-863
    • Hemming, V.G.1
  • 17
    • 84884925820 scopus 로고    scopus 로고
    • Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms
    • Leon, G. et al. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. Toxicon: Official Journal of the International Society on Toxinology 76, 63-76 (2013).
    • (2013) Toxicon: Official Journal of the International Society on Toxinology , vol.76 , pp. 63-76
    • Leon, G.1
  • 18
    • 0027053416 scopus 로고
    • PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a phase I trial of hyperimmune porcine immunoglobulin to HIV-1
    • Osther, K. et al. PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a phase I trial of hyperimmune porcine immunoglobulin to HIV-1. Aids 6, 1457-1464 (1992).
    • (1992) Aids , vol.6 , pp. 1457-1464
    • Osther, K.1
  • 19
    • 84886259619 scopus 로고    scopus 로고
    • Physiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattle
    • Sano, A. et al. Physiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattle. Plos one 8, doi: 10.1371/journal.pone.0078119 (2013).
    • (2013) Plos One , vol.8
    • Sano, A.1
  • 20
    • 84897432390 scopus 로고    scopus 로고
    • Triple immunoglobulin gene knockout transchromosomic cattle: Bovine lambda cluster deletion and its effect on fully human polyclonal antibody production
    • Matsushita, H. et al. Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production. Plos one 9, doi: 10.1371/journal.pone.0090383 (2014).
    • (2014) Plos One , vol.9
    • Matsushita, H.1
  • 21
    • 59849097833 scopus 로고    scopus 로고
    • Antigen-specific human polyclonal antibodies from hyperimmunized cattle
    • Kuroiwa, Y. et al. Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nat Biotechnol 27, 173-181 (2009).
    • (2009) Nat Biotechnol , vol.27 , pp. 173-181
    • Kuroiwa, Y.1
  • 22
    • 84939129686 scopus 로고    scopus 로고
    • Species-Specific Chromosome Engineering Greatly Improves Fully Human Polyclonal Antibody Production Profile in Cattle
    • Matsushita, H. et al. Species-Specific Chromosome Engineering Greatly Improves Fully Human Polyclonal Antibody Production Profile in Cattle. PLos One 10, doi: 10.1371/ journal.pone.0130699 (2015).
    • (2015) PLos One , vol.10
    • Matsushita, H.1
  • 23
    • 84914128755 scopus 로고    scopus 로고
    • DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome
    • 264ra162
    • Hooper, J. W. et al. DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome. Sci Transl Med 6, 264ra162, doi: 10.1126/scitranslmed.3010082 (2014).
    • (2014) Sci Transl Med , vol.6
    • Hooper, J.W.1
  • 24
    • 82955233820 scopus 로고    scopus 로고
    • A shared structural solution for neutralizing ebolaviruses
    • Dias, J. M. et al. A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol 18, 1424-1427 (2011).
    • (2011) Nat Struct Mol Biol , vol.18 , pp. 1424-1427
    • Dias, J.M.1
  • 25
    • 85011081815 scopus 로고    scopus 로고
    • A Recombinant Vesicular Stomatitis Virus Ebola Vaccine - Preliminary Report
    • April 1, 2015
    • Regules, J. A. et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine - Preliminary Report. N Engl J Med April 1, 2015, doi: 10.1056/NEJMoa1414216 (2015).
    • (2015) N Engl J Med
    • Regules, J.A.1
  • 26
    • 77953009742 scopus 로고    scopus 로고
    • Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus
    • 15ra5
    • Khurana, S. et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci Transl Med 2, 15ra5, doi: 10.1126/scitranslmed.3000624 (2010).
    • (2010) Sci Transl Med , vol.2
    • Khurana, S.1
  • 27
    • 79957840765 scopus 로고    scopus 로고
    • MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
    • 85ra48
    • Khurana, S. et al. MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines. Sci Transl Med 3, 85ra48, doi: 10.1126/scitranslmed.3002336 (2011).
    • (2011) Sci Transl Med , vol.3
    • Khurana, S.1
  • 28
    • 0034051595 scopus 로고    scopus 로고
    • Epitopes involved in antibody-mediated protection from Ebola virus
    • Wilson, J. A. et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287(5458), 1664-1666 (2000).
    • (2000) Science , vol.287 , Issue.5458 , pp. 1664-1666
    • Wilson, J.A.1
  • 29
    • 84859206023 scopus 로고    scopus 로고
    • Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection
    • Qiu, X. et al. Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLos Negl Trop Dis 6(3), p. e1575, doi: 10.1371/journal.pntd.0001575 (2012).
    • (2012) PLos Negl Trop Dis , vol.6 , Issue.3 , pp. e1575
    • Qiu, X.1
  • 30
    • 84939448030 scopus 로고    scopus 로고
    • Rapid Manufacture and Release of a GMP Batch of Zaire Ebolavirus Glycoprotein Vaccine Made Using Recombinant Baculovirus-Sf9 Insect Cell Culture Technology
    • Hahn, T. J. et al. Rapid Manufacture and Release of a GMP Batch of Zaire Ebolavirus Glycoprotein Vaccine Made Using Recombinant Baculovirus-Sf9 Insect Cell Culture Technology. Bioprocessing Journal 14, 6-15 (2015).
    • (2015) Bioprocessing Journal , vol.14 , pp. 6-15
    • Hahn, T.J.1
  • 31
    • 84920797859 scopus 로고    scopus 로고
    • Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein
    • Martins, K. et al. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein. Viral Immunol 28(1), p. 62-70 (2015).
    • (2015) Viral Immunol , vol.28 , Issue.1 , pp. 62-70
    • Martins, K.1
  • 32
    • 0031688699 scopus 로고    scopus 로고
    • A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever
    • Bray, M. et al. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 178(3), p. 651-61 (1998).
    • (1998) J Infect Dis , vol.178 , Issue.3 , pp. 651-661
    • Bray, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.